EAM
KMTS

Eventide Asset Management’s Kestra Medical Technologies KMTS Stock Holding History

Eventide Asset Management’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.8M Buy
1,445,864
+176,213
+14% +$4.15M 0.48% 72
2025
Q4 		$33.7M Buy
1,269,651
+65,288
+5% +$1.68M 0.53% 66
2025
Q3 		$28.6M Buy
1,204,363
+143,806
+14% +$2.57M 0.47% 80
2025
Q2 		$17.6M Buy
1,060,557
+785,557
+286% +$17.2M 0.31% 100
2025
Q1 		$6.85M Buy
+275,000
New +$6.32M 0.14% 134

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Eventide Asset Management's KMTS Position: Q1 2026 in Review

Eventide Asset Management increased its Kestra Medical Technologies (KMTS) stake by 14% in Q1 2026, buying an estimated $4.15M and bringing the position to 1,445,864 shares worth $28.8M. The position accounts for 0.48% of the portfolio, ranked #72.

Eventide Asset Management first reported a position in KMTS in Q1 2025 and has held it in 5 quarters since. The position peaked at $33.7M in Q4 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Eventide Asset Management held 1,445,864 shares of Kestra Medical Technologies worth $28.8M as of Q1 2026.
  • Eventide Asset Management bought 176,213 Kestra Medical Technologies shares in Q1 2026, an estimated $4.15M.
  • Kestra Medical Technologies made up 0.48% of Eventide Asset Management's portfolio in Q1 2026, its #72 holding.
  • Eventide Asset Management first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 5 quarters since.
  • Eventide Asset Management's Kestra Medical Technologies position peaked at $33.7M in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Eventide Asset Management's 13F filing for Q1 2026, filed 15 May 2026.